Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan Duggan

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
American Journal of Respiratory Cell and Molecular Biology|August 2, 2019
Improving the Quality and Reproducibility of Flow Cytometry in the Lung. An Official American Thoracic Society Workshop ReportRobert M Tighe, Elizabeth F Redente, Yen-Rei Yu, et al.
ACS Chemical Biology|April 3, 2019
Small Molecule and Pooled CRISPR Screens Investigating IL17 Signaling Identify BRD2 as a Novel Contributor to Keratinocyte Inflammatory ResponsesPeter F Slivka, Chen-Lin Hsieh, Alex Lipovsky, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2015
Reduced DOCK4 expression leads to erythroid dysplasia in myelodysplastic syndromesSriram Sundaravel, Ryan Duggan, Tushar Bhagat, et al.
Cancer Discovery|September 5, 2020
Venetoclax Increases Intratumoral Effector T Cells and Antitumor Efficacy in Combination with Immune Checkpoint BlockadeFrederick J Kohlhapp, Dipica Haribhai, Rebecca Mathew, et al.
Heliyon|September 10, 2024
Navitoclax safety, tolerability, and effect on biomarkers of senescence and neurodegeneration in aged nonhuman primatesEdward F Greenberg, Martin J Voorbach, Alexandra Smith, et al.
Blood|May 3, 2024
ABBV-319: a CD19-targeting glucocorticoid receptor modulator antibody-drug conjugate therapy for B-cell malignanciesChewei Anderson Chang, Ethan Emberley, Aloma L D'Souza, et al.
Nature|October 4, 2023
The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunityChristina K Baumgartner, Hakimeh Ebrahimi-Nik, Arvin Iracheta-Vellve, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
American Journal of Respiratory Cell and Molecular Biology|August 2, 2019
Improving the Quality and Reproducibility of Flow Cytometry in the Lung. An Official American Thoracic Society Workshop ReportRobert M Tighe, Elizabeth F Redente, Yen-Rei Yu, et al.
ACS Chemical Biology|April 3, 2019
Small Molecule and Pooled CRISPR Screens Investigating IL17 Signaling Identify BRD2 as a Novel Contributor to Keratinocyte Inflammatory ResponsesPeter F Slivka, Chen-Lin Hsieh, Alex Lipovsky, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2015
Reduced DOCK4 expression leads to erythroid dysplasia in myelodysplastic syndromesSriram Sundaravel, Ryan Duggan, Tushar Bhagat, et al.
Cancer Discovery|September 5, 2020
Venetoclax Increases Intratumoral Effector T Cells and Antitumor Efficacy in Combination with Immune Checkpoint BlockadeFrederick J Kohlhapp, Dipica Haribhai, Rebecca Mathew, et al.
Heliyon|September 10, 2024
Navitoclax safety, tolerability, and effect on biomarkers of senescence and neurodegeneration in aged nonhuman primatesEdward F Greenberg, Martin J Voorbach, Alexandra Smith, et al.
Blood|May 3, 2024
ABBV-319: a CD19-targeting glucocorticoid receptor modulator antibody-drug conjugate therapy for B-cell malignanciesChewei Anderson Chang, Ethan Emberley, Aloma L D'Souza, et al.
Nature|October 4, 2023
The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunityChristina K Baumgartner, Hakimeh Ebrahimi-Nik, Arvin Iracheta-Vellve, et al.
Pageof 2